Biosafety Cabinet Market is expected to reach US$ 429.47 million by 2028

In 2022, Class II Type A2 and Class II Type B1 Segment, by Type, Held Largest Share of Biosafety Cabinet Market

According to our new research study on "Biosafety Cabinet Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Products Handled, Category, Type, Application, and End User," the market is expected to grow from US$ 276.88 million in 2022 to US$ 429.47 million by 2028; it is estimated to register a CAGR of 7.6% during 2023–2028.

Biosafety cabinets are efficient devices used to control contamination in laboratories dealing with infectious agents. These act as a primary barrier for restricting the escape of biological aerosols in the lab environment. The biosafety cabinets are broadly classified in three types —class I cabinets, class II cabinets, and class III cabinets. Specific regulations and guidelines imposed by the medical ruling authorities in each region recommend the use of the appropriate type of cabinets to carry out protocols based on the levels of risk involved. The rising prevalence of infectious diseases and increasing strategic initiatives are bolstering the biosafety cabinet market size. The biosafety cabinet market trend includes the increasing adoption of cell-based and regenerative therapies. Moreover, the biosafety cabinet market size is likely to grow by 2028 owing to rapid developments in pharmaceutical and biotechnology research.

Biosafety Cabinet Market, by Type, 2022 & 2028 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPHE100001226

Source: The Insight Partners Analysis

Based on products handled, the biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment accounted for a larger market share in 2022. However, the toxic products segment is expected to record a higher CAGR of the biosafety cabinet market during the forecast period. Biological products include blood samples and components, allergenic, vaccines, stem cells, gene therapies, tissues, and recombinant therapeutic proteins that require high protection as they are prone to quick contamination due to their complex characteristics. These products require a sterile work zone. Here, biosafety cabinets provide an effective, optimized environment to store biological products for a longer period. Class II and III biosafety cabinets are widely used to store biological products in research laboratories and research and development facilities of healthcare companies. These cabinets utilize high-efficiency particulate air (HEPA) filters to prevent biohazard exposure.

Impact of COVID-19 Pandemic on Biosafety Cabinet Market

Demand for biosafety cabinets upsurged during COVID-19 outbreak as the focus of healthcare was on saving lives and conducting a maximum number of tests possible each day to increase diagnosis to manage the disease. COVID-19 was causing massive disruptions in global supply chains, consumer markets, and the economy as a whole. However, as per the regulations by Centers of Disease Control and Prevention (CDC) and World Health Organization (WHO), live sample testing is mandatory to be performed in a controlled environment, which fueled the demand for biosafety cabinets. The COVID-19 pandemic has created a significant demand for biosafety cabinets to test and develop COVID-19 vaccines and drugs to cope with the outbreak. Therefore, COVID-19 pandemic has a positive impact on the biosafety cabinet market growth. 

NuAire Inc, Labconco Corp, Esco Group of Companies, Biobase Biodusty Co Ltd, Thermo Fisher Scientific Inc, IMSET, Heal Force Bio-Meditech Holdings Ltd, Kewaunee Scientific Corp, ACMAS Technologies, and Haier Biomedical are among the leading companies operating in the biosafety cabinet market. 

The report segments the biosafety cabinet market as follows:

The global biosafety cabinet market is segmented on the basis of products handled, category, type, application, and end user. Based on products handled, the market is bifurcated into biological products and toxic products. Based on category, the market is segmented into work trays, side panel construction, and accessories. Based on type, the market is segmented into class I biosafety cabinet, class II type A2 and class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. Based on application, the global biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. Based on end user, the market is segmented into academic centers, biotech and pharmaceutical companies, microbiology centers, research and development centers, hospitals and clinics, diagnostic laboratories, and others.

Based on geography, the biosafety cabinet market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East (the UAE, Saudi Arabia, Kuwait, Egypt, and the Rest of Middle East), Africa (South Africa, Nigeria, Kenya, and the Rest of Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).